We won’t succeed alone

Here at GreenLight, we believe we are stronger together. With a united force, we will make a positive change across the globe.

Having dedicated, consistent partners in both academia and industry encourages us to remain scientifically imaginative and passionately focused on making a difference in the world.

The goal is to establish a successful and affordable commercial RNA marketplace. To date, we have collaborated with academic research institutions and strategic corporate partners spanning the agricultural, pharmaceutical, consumer goods, and energy industries.

Our key collaborators have the same goal of commercialized RNA.

Partner with us if you have interests in:

  • Validating research: You can use our platform to validate the impact of research and create a clear path to production.
  • Accelerating production at a reduced cost: Our platform reduces the cost of development and enables industrial-scale production (by the kilogram) for commercial RNA products.
  • Ensuring all industry standards are met: Our process can help guarantee RNA-based products are manufactured to meet the quality standards of your particular industry.
  • Advancing RNA capabilities in lower-income countries: Our vision is to enable Africa, Asia, and Latin America to meet local demand through local production.

As a partner, you will have unrestricted access to our platform which uses a clean, cell-free RNA production process. This process will inevitably lead to the development of plant and life sciences.

Improve plant sciences

Many pesticides are toxic, and some that were previously approved are now banned. With targeted biocontrol we attack the pest—not the plant or beneficial insects—to help farmers grow healthy crops with healthy yields. 

Advance life sciences

Drug companies know messenger RNA (mRNA) as an effective means to stop the spread of infectious disease. But creating vaccines is a slow process, and one that is difficult to scale. Our flexible RNA platform offers the potential for rapid vaccine production coupled with scalable, high-fidelity manufacturing.